RIDGEBACK CAPITAL MANAGEMENT
Ridgeback Capital is an investment firm that provides financial support for life science companies.
Business Model:
Revenue: $0
Employees: 0-0
Rankings
Industries / Tags:
Detailed RIDGEBACK CAPITAL MANAGEMENT Information
Geographic Data
Address:
City:
State:
Zip:
Country:
Financial Info
Stage:
Raised Last:
$0
Raised Total:$0
Social
Linkedin
Crunchbase
Metrics
0Website Global Rank
0Website Monthly Traffic
Twitter Followers
Description
Ridgeback Capital is an investment firm that provides financial support for life science companies.
Contact Phone:
Contact Email:
| Announced Date | Company | Transaction | Money Raised |
|---|---|---|---|
| 9/2021 | Garuda Therapeutics | Series A | 72M |
| 2/2021 | Butterfly Network | Post-IPO Equity | 175M |
| 9/2015 | Selecta Biosciences | Series E | 38M |
| 1/2021 | Senti Biosciences | Series B | 105M |
| 3/2021 | Caribou Biosciences | Series C | 115M |
| 11/2021 | Quell Therapeutics | Series B | 0 |
| 3/2007 | Microbia | Series F | 50M |
| 7/2021 | Turnstone Biologics | Series D | 0 |
| 9/2020 | Eledon Pharmaceuticals | Post-IPO Equity | 108M |
| 11/2018 | Harpoon Therapeutics | Series C | 70M |
| 11/2021 | Arbor Biotechnologies | Series B | 0 |
| 6/2020 | 4D Molecular Therapeutics | Series C | 0 |
| 1/2020 | TwinStrand Biosciences | Series A | 16M |
| 8/2020 | ESSA Pharma | Post-IPO Equity | 0 |
| 2/2022 | Crisp | Series B | 0 |
| 1/2021 | Aro Biotherapeutics | Series A | 88M |
| 2/2021 | Viracta Therapeutics | Post-IPO Equity | 65M |
| 3/2021 | Pyxis Oncology | Series B | 152M |
| 12/2013 | Stem Cell Therapeutics | Post-IPO Equity | 0 |
| 6/2018 | Precision BioSciences | Series B | 0 |
| 4/2006 | Alveolus | Series C | 15M |
| 2/2021 | Reverie Labs | Series A | 25M |
| 12/2021 | Freenome | Series D | 300M |
| 5/2021 | TwinStrand Biosciences | Series B | 50M |
| 3/2021 | Acepodia | Series B | 47M |
| 9/2014 | Adaptimmune | Series A | 0 |
| 9/2018 | 4D Molecular Therapeutics | Series B | 0 |
| 8/2014 | Bellicum Pharmaceuticals | Series C | 55M |
| 2/2022 | Crisp | Series B | 0 |
| 12/2021 | Freenome | Series D | 0 |
| 11/2021 | Quell Therapeutics | Series B | 0 |
| 11/2021 | Arbor Biotechnologies | Series B | 0 |
| 9/2021 | Garuda Therapeutics | Series A | 0 |
| 7/2021 | Turnstone Biologics | Series D | 0 |
| 5/2021 | TwinStrand Biosciences | Series B | 0 |
| 3/2021 | Pyxis Oncology | Series B | 0 |
| 3/2021 | Acepodia | Series B | 0 |
| 3/2021 | Caribou Biosciences | Series C | 0 |
Startup Industries
Startup Locations
Portfolio Current Status
Portfolio Employee Count
| Name | Price |
|---|
| Name | Size | Announced Date |
|---|
